Status:
COMPLETED
Efficacy of Enteral Iron Supplementation in Critical Illness
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Anemic, Critically Ill Patients
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate the efficacy of enteral iron supplementation for improving anemia, decreasing the risk of blood transfusion, and decreasing mortality in patients who are ho...
Detailed Description
Critical illness is characterized by the anemia of inflammation, which is partially caused by sequestration of iron from bone marrow sites of erythropoiesis into storage within the reticuloendothelial...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Anemia (Hemoglobin \< 13.0 g/dL)
- ≤ 72 hours from hospital admission
- Current tolerance of enteral medications
- Expected ICU LOS \> 5 days
Exclusion
- Active bleeding
- Chronic inflammatory disease
- End-stage renal disease
- Hematologic disorders
- Macrocytic anemia
- Current use of erythropoietin
- Pregnancy
- Prohibition of RBC transfusions
- Moribund state in which death is imminent
- Enrollment in another clinical trial
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00450177
Start Date
January 1 2006
End Date
January 1 2008
Last Update
July 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Medical College of Cornell University
New York, New York, United States, 10021